(Reuters) - The U.S. Food and Drug Administration approved Eli Lilly and Co's treatment for severe hypoglycemia, the health regulator said on Wednesday. Hypoglycemia is a condition in which blood sugar falls to dangerously low levels.
from Google Alert - health https://ift.tt/2SFSzPp
via IFTTT
0 comments:
Post a Comment